A detailed history of Raleigh Capital Management Inc. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 7 shares of WST stock, worth $2,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 8 12.5%
Holding current value
$2,080
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$314.68 - $395.94 $314 - $395
-1 Reduced 12.5%
7 $2,000
Q1 2024

May 13, 2024

SELL
$338.27 - $413.0 $27,399 - $33,453
-81 Reduced 91.01%
8 $3,000
Q4 2023

Feb 21, 2024

BUY
$318.29 - $392.21 $2,228 - $2,745
7 Added 8.54%
89 $31,000
Q3 2023

Dec 06, 2023

BUY
$354.9 - $412.41 $709 - $824
2 Added 2.5%
82 $30,000
Q2 2023

Jul 25, 2023

BUY
$334.63 - $382.47 $26,770 - $30,597
80 New
80 $30,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $22B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.